Annji Pharmaceutical Co., Ltd.

China

 
Total IP 10
Total IP Rank # 154,777
IP Activity Score 1.4/5.0    5
IP Activity Rank # 196,898

Patents

Trademarks

0 0
3 0
7 0
0
 
Last Patent 2023 - Topical formulation of dimethylc...
First Patent 2013 - Multifunctional quinoline deriva...

Latest Inventions, Goods, Services

2022 Invention Topical formulation of dimethylcurcumin. Provided is a pharmaceutical composition that may be sui...
2021 Invention Quinazoline derivatives useful as selective hdac6 inhibitors. e.g.e.g., in the treatment of neuro...
Invention Quinazoline derivatives useful as selective hdac6 inhibitors. Provided herein is a compound of Fo...
2018 Invention Histone deacetylases (hdacs) inhibitors. Histone deacetylases (HDACs) inhibitors of Formula...
Invention Histone deacetylases (hdacs) inhibitors. Histone deacetylases (HDACs) inhibitors are disclosed. T...
2013 Invention Indolin-2-one derivatives as protein kinase inhibitors. A novel class of indoline-2-one derivativ...
Invention Multifunctional quinoline derivatives as anti-neurodegenerative agents. Novel quinolone derivativ...
Invention Cyclopropanecarboxylate esters of purine analogues. Cydopropanecarboxylate esters of purine analo...
Invention Histone deacetylases (hdacs) inhibitors. Methods of treating diseases and conditions wherein inhi...